Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
The introduction of anti-vascular endothelial growth factor (VEGF) agents has revolutionized therapy for a host of ocular diseases associated with leakage from normal blood vessels and pathologic blood vessel growth.
The introduction of anti-vascular endothelial growth factor (VEGF) agents has revolutionized therapy for a host of ocular diseases associated with leakage from normal blood vessels and pathologic blood vessel growth.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Jay S. Duker, MD, is Professor and Chairman of Ophthalmology at the Tufts Medical Center and Tufts University School of Medicine and Director of the New England Eye Center in Boston, Massachusetts. Dr. Duker graduated from Jefferson Medical College and completed ophthalmology and retina training at the Wills Eye Hospital. His research and clinical interests are focused on the posterior segment ranging from macular degeneration, diabetic retinopathy, and retinal vascular diseases, as well as uveitis and intraocular tumors. He has published more than 280 journal articles and has been lead editor on six books and dozens of book chapters. Dr. Duker is the co-editor of the International Journal of Retina and Vitreous.
Michelle C. Liang, MD, is Assistant Professor of Ophthalmology at the Tufts University School of Medicine and a vitreoretinal specialist at the New England Eye Center in Boston, Massachusetts. She graduated with honors from Johns Hopkins University with a degree in Biology and earned her medical degree from the University at Buffalo School of Medicine and Biomedical Sciences. She performed her residency in ophthalmology at the New England Eye Center at Tufts Medical Center and went on to complete a vitreoretinal surgery fellowship at the New England Eye Center and Ophthalmic Consultants of Boston. Dr. Liang has authored numerous scientific papers and book chapters and has presented at several national meetings. She treats all conditions of the retina and vitreous, including macular degeneration, vitreomacular disorders, diabetic retinopathy, retinal vascular disorders, retinal detachment, and cataract complications. Her research interests include retinal imaging and new therapies for macular degeneration, diabetic macular edema, and other diseases. Dr. Liang is a board-certified member of the American Board of Ophthalmology and a member of the American Academy of Ophthalmology and American Society of Retinal Specialists.
Inhaltsangabe
Dedication About the Editors Contributing AuthorsIntroduction Section I Overview of Anti-Vascular Endothelial Growth Factor Agents Chapter 1 Vascular Endothelial Growth Factor: Background and HistoryAnthony Joseph MD and Ehsan Rahimy MD Chapter 2 Development of Anti-Vascular Endothelial Growth Factor AgentsMaya H. Maloney MD and Sophie J. Bakri MD Chapter 3 Available Anti-Vascular Endothelial Growth Factor AgentsAngeline Mariani Derham MD and David M. Brown MD FACS Chapter 4 Agents Under Study Ehsan Rahimy MD; Elham Rahimy BS; and Anthony Joseph MD Chapter 5 Intravitreal DeliveryNora Muakkassa MD; Kendra Klein MD; and Elias Reichel MD Chapter 6 Sustained Delivery Options Under StudyMichael N. Cohen MD; Chirag P. Shah MD MPH; and Jeffrey S. Heier MD Section II Use of Anti-Vascular Endothelial Growth Factor Agents in Clinical Practice Chapter 7 Neovascular Age-Related Macular DegenerationMichael D. Lewen MD and Andre J. Witkin MD Chapter 8 Choroidal Neovascularization Not Age-Related Macular DegenerationDarin R. Goldman MD Chapter 9 Diabetic Macular EdemaEmily D. Cole BS; Eduardo A. Novais MD; and Nadia K. Waheed MD MPH Chapter 10 Proliferative Diabetic RetinopathySabin Dang MD and Chirag P. Shah MD MPH Chapter 11 Retinal Vein OcclusionShilpa Desai MD and Caroline R. Baumal MD Chapter 12 UveitisLana M. Rifkin MD Chapter 13 Retinopathy of PrematurityNikisha A. Kothari MD and Audina M. Berrocal MD Chapter 14 Miscellaneous Retinal and Choroidal DiseasesMichael D. Tibbetts MD Chapter 15 Neovascular GlaucomaManik Goel MD and Joel S. Schuman MD FACS Chapter 16 Glaucoma SurgeryJessica J. Moon MD and Cynthia Mattox MD Chapter 17 Anterior Segment DiseasesAlessandro Abbouda MD; Bijan Khaksari BA; and Pedram Hamrah MD FRCSFinancial Disclosures Index
Dedication About the Editors Contributing AuthorsIntroduction Section I Overview of Anti-Vascular Endothelial Growth Factor Agents Chapter 1 Vascular Endothelial Growth Factor: Background and HistoryAnthony Joseph MD and Ehsan Rahimy MD Chapter 2 Development of Anti-Vascular Endothelial Growth Factor AgentsMaya H. Maloney MD and Sophie J. Bakri MD Chapter 3 Available Anti-Vascular Endothelial Growth Factor AgentsAngeline Mariani Derham MD and David M. Brown MD FACS Chapter 4 Agents Under Study Ehsan Rahimy MD; Elham Rahimy BS; and Anthony Joseph MD Chapter 5 Intravitreal DeliveryNora Muakkassa MD; Kendra Klein MD; and Elias Reichel MD Chapter 6 Sustained Delivery Options Under StudyMichael N. Cohen MD; Chirag P. Shah MD MPH; and Jeffrey S. Heier MD Section II Use of Anti-Vascular Endothelial Growth Factor Agents in Clinical Practice Chapter 7 Neovascular Age-Related Macular DegenerationMichael D. Lewen MD and Andre J. Witkin MD Chapter 8 Choroidal Neovascularization Not Age-Related Macular DegenerationDarin R. Goldman MD Chapter 9 Diabetic Macular EdemaEmily D. Cole BS; Eduardo A. Novais MD; and Nadia K. Waheed MD MPH Chapter 10 Proliferative Diabetic RetinopathySabin Dang MD and Chirag P. Shah MD MPH Chapter 11 Retinal Vein OcclusionShilpa Desai MD and Caroline R. Baumal MD Chapter 12 UveitisLana M. Rifkin MD Chapter 13 Retinopathy of PrematurityNikisha A. Kothari MD and Audina M. Berrocal MD Chapter 14 Miscellaneous Retinal and Choroidal DiseasesMichael D. Tibbetts MD Chapter 15 Neovascular GlaucomaManik Goel MD and Joel S. Schuman MD FACS Chapter 16 Glaucoma SurgeryJessica J. Moon MD and Cynthia Mattox MD Chapter 17 Anterior Segment DiseasesAlessandro Abbouda MD; Bijan Khaksari BA; and Pedram Hamrah MD FRCSFinancial Disclosures Index
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
